Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

April 1, 2017

Study Completion Date

May 1, 2017

Conditions

HyperuricemiaHemodialysis Complication

Interventions

DRUG

Febuxostat 40 milligramsTablet

Febuxostat 40 milligramsTablet every other day for 3 months

All Listed Sponsors

collaborator

New Jeddah Clinic Hospital

INDUSTRY

lead

Benha University

OTHER

NCT03149939 - Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients | Biotech Hunter | Biotech Hunter